Long-term immune response to mRNA anti-SARS-CoV-2 vaccination in patients with cancer.

Front Immunol · 2026 · PMC13231279 · PMID 42245650

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In contrast, the increases observed in cohort A.3 (from 3, 875 U/mL to 25, 094 U/mL [IQR, 3, 666–62, 819], p=0.31) and cohort B (from 330 U/mL to 1, 504 U/mL [IQR, 287–21, 182], p=0.22) did not reach statistical significance ( Figure 2G ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.